Solbec Pharmaceuticals Limited
News
SOLBEC PHARMACEUTICALS LIMITED (ASX: SBP) - Market Briefing - Mr Stephen Carter, Managing Director; Boardroomradio is pleased to announce that SOLBEC PHARMACEUTICALS LIMITED (ASX: SBP) has published a
Coramsine R receives Orphan Drug Designation for the treatment of metastatic Renal
Cell Carcinoma from the United States Food and Drug Administration
###
4,234 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 5) (Last 30 Days: 22) (Since Published: 4234)